This trial studied snoring and sleep apnea treatment with a MAD device in patients with OPC. Results show mixed success.
- Oral Cancers
- Sleep Apnea
- Throat Cancer
- Oral Squamous Cell Carcinoma
2 Primary · 1 Secondary · Reporting Duration: Done in morning from 6-8 sleep period, assessed in morning of each of 3 nights
2 Treatment Groups
1 of 2
Neutral MAD- control
1 of 2
35 Total Participants · 2 Treatment Groups
Primary Treatment: MAD-active · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 65 · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
- Dal Fabbro C, Harris P, Dufresne E, Herrero Babiloni A, Mayer P, Bahig H, Filion E, Nguyen F, Ghannoum J, Schmittbuhl M, Lavigne G. Orofacial Pain and Snoring/Obstructive Sleep Apnea in Individuals with Head and Neck Cancer: A Critical Review. J Oral Facial Pain Headache. 2022 Spring;36(2):85-102. doi: 10.11607/ofph.3176.
- Gilles Lavigne 2023. "Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05719779.
Frequently Asked Questions
Is the age eligibility for this medical study restricted to those over 40 years old?
"This clinical experiment necessitates that participants are aged 18 to 65. There is a total of 44 separate trials for those younger than 18 and 777 dedicated studies for seniors above the age of 65." - Anonymous Online Contributor
Are there any openings for persons wishing to participate in this clinical trial?
"Absolutely. Clinicaltrials.gov confirms that the trial is currently recruiting, which commenced on February 3rd 2023 and was last updated on May 9th 2023. 35 participants will be recruited from a single site." - Anonymous Online Contributor
To what extent is this experiment involving human participants?
"Yes, the information on clinicaltrials.gov confirms that this research project is currently recruiting participants. This trial was initially advertised on February 3rd 2023 and recently updated on May 9th of the same year. Participants for this experiment will be accepted from one centre, with a total enrolment of 35 individuals." - Anonymous Online Contributor
Is there an opportunity to join this experiment?
"For this medical experiment, 35 people aged 18-65 with oral cancers are being recruited. The ideal candidate should have a diagnosis of oropharyngeal cancer and be either male or female; preference is given to males in a 1:4 ratio. Additionally, they must have undergone radiation therapy at the Radiation Oncology Department and report having snoring issues and/or breathing cessation while sleeping." - Anonymous Online Contributor